Personal information

Postdoctoral researcher at University of Glasgow
United Kingdom

Biography

A postdoctoral researcher interested and working in Glioblastoma (Brain tumors)

Activities

Employment (3)

University of Glasgow: Glasgow, GB

2022-08-01 to present | Postdoctoral Researcher (Wolfson Wohl Cancer Research Centre)
Employment
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

SYNLAB: Helsinki, FI

2022-01-05 to 2022-07-07 | Bioanalyst (COVID19 Laboratory)
Employment
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

University of Helsinki: Helsinki, FI

2015-08-04 to 2021-12-31 | Doctoral researcher (TRANS­LA­TIONAL CANCER MEDICINE PROGRAM (CAN-PRO))
Employment
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Education and qualifications (3)

University of Helsinki: Helsinki, FI

2015-08-04 to 2021-12-31 | PhD (Translational Cancer Medicine Program)
Education
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Universite de Lorraine LIMBP: Metz, Lorraine, FR

2014-09-02 to 2015-07-31 | MSc-RNA Biology
Education
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

SRM Group of Educational Institutions: Chennai, Tamil Nadu, IN

2008-08-11 to 2012-08-20 | B.Tech (Genetic Engineering)
Education
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Professional activities (2)

Finnish Brain Tu­mor Research As­so­ci­ation (FiB­TRA): Helsinki, FI

2016-08-01 to present | Annual
Membership
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Finnish Brain Tu­mor Research As­so­ci­ation (FiB­TRA): Helsinki, FI

2018-11-30 | Best Oral presentation award
Distinction
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Funding (6)

Cancer neuroscience: role of cell surface Proteins in neural development and neuron-cancer crosstalk.

2021-05 to 2021-08 | Grant
Ida Montinin Säätiö (Helsinki, FI)
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Cancer neuroscience: role of cell surface Proteins in neural development and neuron-cancer crosstalk

2020-10 to 2020-12 | Grant
Finnish Cancer Foundation (Helsinki, FI)
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

DsHealth Chancellor´s Travel Grant

2018-03 to 2018-05 | Award
University of Helsinki (Helsinki, FI)
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

CSHL-Development and 3D modelling of Human brain

2017-08 to 2018-01 | Grant
University of Helsinki (Helsinki, FI)
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Cold Spring Harbor course on Brain Tumors

2016-08 to 2016-08 | Award
American Brain Tumor Association (IL, IL, US)
GRANT_NUMBER: Class of 2016
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

European Training Network-MagicBullet

2015-08 to 2018 | Grant
Horizon 2020 Framework Programme (Brussels, BE)
Part of GRANT_NUMBER: 642004.
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Works (49)

Data from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Data S1. from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Data S1. from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure Legends from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure Legends from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary table S1 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary table S1 from Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2024-09-16 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas J.J. Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Data from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Molecular Cancer Therapeutics
2023-11-01 | Journal article
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Data S1. from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Data S1. from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure Legends from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure Legends from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary table S1 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Supplementary table S1 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

2023-11-01 | Preprint
Contributors: Hector J. Monzo; Kerttu Kalander; Marko M. Hyytiäinen; Endrit Elbasani; Johanna Wall; Lidia Moyano-Galceran; Jayendrakishore Tanjore Ramanathan; Joonas Jukonen; Pirjo Laakkonen; Ari Ristimäki et al.
Source: check_circle
Crossref

Immunoglobulin superfamily member 3 is required for the vagal neural crest cell migration and enteric neuronal network organization.

Scientific reports
2023-10-11 | Journal article
Contributors: Tanjore Ramanathan J; Zárybnický T; Filppu P; Monzo HJ; Monni O; Tervonen TA; Klefström J; Kerosuo L; Kuure S; Laakkonen P
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan

Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

2022-09-06 | Preprint
Contributors: HJ Monzo; M Hyytiäinen; E Elbasani; K Kalander; J Wall; L Moyano-Galceran; J Tanjore-Ramanathan; J Jukonen; P Laakkonen; A Ristimäki et al.
Source: check_circle
Crossref

Bivalent EGFR-Targeting DARPin-MMAE Conjugates

International Journal of Molecular Sciences
2022-02-23 | Journal article
Contributors: Lennard Karsten; Nils Janson; Vadim Le Joncour; Sarfaraz Alam; Benjamin Müller; Jayendrakishore Tanjore Ramanathan; Pirjo Laakkonen; Norbert Sewald; Kristian M. Müller
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity

JCI Insight
2021-05-10 | Journal article
Contributors: Pauliina Filppu; Jayendrakishore Tanjore Ramanathan; Kirsi J. Granberg; Erika Gucciardo; Hannu Haapasalo; Kaisa Lehti; Matti Nykter; Vadim Le Joncour; Pirjo Laakkonen
Source: check_circle
Crossref

Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain

Journal of Cellular and Molecular Medicine
2020-06 | Journal article
Contributors: Jayendrakishore Tanjore Ramanathan; Suvi Lehtipuro; Harri Sihto; József Tóvári; Lilla Reiniger; Vanda Téglási; Judit Moldvay; Matti Nykter; Hannu Haapasalo; Vadim Le Joncour et al.
Source: check_circle
Crossref

α6β1- and αV-integrins are required for long-term self-renewal of murine embryonic stem cells in the absence of LIF.

BMC cell biology
2015-02-27 | Journal article
Part of PMC: PMC4348401
Source: Self-asserted source
Jayendrakishore Tanjore Ramanathan